Afya Limited
NasdaqGS:AFYA Stock Report
Afya Future Growth
Future criteria checks 2/6 Afya is forecast to grow earnings and revenue by 15.2% and 10.1% per annum respectively. EPS is expected to grow by 19.5% per annum. Return on equity is forecast to be 19.6% in 3 years.
Key information
15.2%
Earnings growth rate
Consumer Services earnings growth 25.6% Revenue growth rate 10.1% Future return on equity 19.6% Analyst coverage Good
Last updated 06 Nov 2024
Recent future growth updates
Afya Limited Updates Financial Guidance for the Year 2024 Aug 15
Afya Limited Provides Earnings Guidance for the FY2024 Mar 15
Consensus EPS estimates fall by 14% Nov 28
Consensus EPS estimates increase by 11% Nov 15
Consensus EPS estimates increase by 12% Mar 24
Consensus forecasts updated Jul 21
Show all updates
Investors Holding Back On Afya Limited (NASDAQ:AFYA) Nov 03
Returns At Afya (NASDAQ:AFYA) Are On The Way Up Oct 18
Afya Limited to Report Q3, 2024 Results on Nov 13, 2024 Oct 18
Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply Aug 29
Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors Aug 29
Second quarter 2024 earnings: EPS exceeds analyst expectations Aug 16
Afya Limited Updates Financial Guidance for the Year 2024 Aug 15
Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)? Aug 15
Afya Limited to Report Q2, 2024 Results on Aug 14, 2024 Jul 24
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly Jul 17
Afya Limited Announces the Resignation of Shobhna Mohn as a Member of the Board of Directors Jul 02
Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate Jun 20
Afya's Results Are Improving And The Market Is Undervaluing It Jun 06
Afya Limited, Annual General Meeting, Jun 05, 2024 May 21
Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention? May 14
Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024 May 12 Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024
First quarter 2024 earnings: EPS and revenues exceed analyst expectations May 10
AFYA: Mr Market Is Mistaken Apr 29
Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)? Apr 27
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly Apr 09
Afya Is Performing Well And Is A Buy Mar 19
Full year 2023 earnings: EPS misses analyst expectations Mar 19
Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%? Mar 17
Afya Limited Provides Earnings Guidance for the FY2024 Mar 15
Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital Feb 10
Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing Jan 21
Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now? Jan 03 Afya Limited to Report Q4, 2023 Results on Mar 14, 2024
These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well Dec 07
Consensus EPS estimates fall by 14% Nov 28
Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations Nov 16
Consensus EPS estimates increase by 11% Nov 15
Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital Nov 02
Afya Limited to Report Q3, 2023 Results on Nov 13, 2023 Oct 05
What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate? Sep 20
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 30
Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist? Aug 17
Afya Limited to Report Q2, 2023 Results on Aug 28, 2023 Jul 26
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind May 26
Afya Limited to Report Q1, 2023 Results on May 24, 2023 May 20
Afya Limited, Annual General Meeting, Jun 15, 2023 May 09
Investor sentiment improves as stock rises 19% Apr 11
Full year 2022 earnings: EPS misses analyst expectations Mar 25
Consensus EPS estimates increase by 12% Mar 24
Afya Announces Changes to Its Board of Directors Dec 10
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 22
Less than half of directors are independent Nov 16
Investor sentiment improved over the past week Oct 27
Afya Limited to Report Q3, 2022 Results on Nov 21, 2022 Oct 22
Second quarter 2022 earnings: EPS and revenues exceed analyst expectations Aug 23
Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance Aug 23
Investor sentiment improved over the past week Aug 02
White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth Jul 28
Afya Limited to Report Q2, 2022 Results on Aug 22, 2022 Jul 22
Consensus forecasts updated Jul 21
First quarter 2022 earnings: EPS exceeds analyst expectations May 24
Investor sentiment deteriorated over the past week May 09
Erste Wv GÜTersloh Gmbh signed a basic agreement to acquire additional 2.4% stake in Afya Limited (NasdaqGS:AFYA) from Nicolau Carvalho Esteves Rosângela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd. May 06
Less than half of directors are independent Apr 27
Afya Limited Announces Changes to its Board of Directors Apr 21
Afya Limited to Report Q1, 2022 Results on May 23, 2022 Apr 19
Afya Limited, Annual General Meeting, Apr 29, 2022 Apr 14
Afya: Margin And Organic Growth Struggles Remain Top Of Mind Apr 14
Full year 2021 earnings: EPS misses analyst expectations Apr 02
Investor sentiment improved over the past week Mar 22
Consensus forecasts updated Mar 09
Afya Limited to Report Q4, 2021 Results on Mar 31, 2022 Mar 06
Investor sentiment improved over the past week Jan 31
Afya On A Grey Price Area Dec 25
Consensus forecasts updated Dec 18
Third quarter 2021 earnings: Revenues exceed analyst expectations Nov 24
Afya: The Longer-Term Growth Story Remains Intact Sep 19
Afya Limited Provides Earnings Guidance for the Second Half of 2021 Aug 28
Second quarter 2021 earnings released Aug 27
Director Laura Carvalho has left the company Aug 10
Bertelsmann SE& Co. KGaA completed the acquisition of 24.7% stake in Afya Limited (NasdaqGS:AFYA) from Bozano Educacional II Fundo de Investimento em Participações manged by Crescera Investimentos. Aug 07
First quarter 2021 earnings released: EPS R$1.16 (vs R$1.09 in 1Q 2020) May 29
Afya to acquire UNIGRANRIO for R$700M May 27
Afya Limited announced that it has received BRL 822 million in funding from SoftBank Investment Advisers (UK) Limited May 05
Full year 2020 earnings released: EPS R$3.15 (vs R$2.03 in FY 2019) May 04
Afya Limited announced that it expects to receive BRL 822 million in funding from SoftBank Investment Advisers (UK) Limited Apr 28
Full year 2020 earnings released: EPS R$3.15 (vs R$2.03 in FY 2019) Apr 11
Afya Limited Provides Revenge Guidance for the Second Half of 2021 Apr 10
Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock Apr 04
New 90-day low: US$21.16 Mar 09
Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive? Mar 09
Is Afya (NASDAQ:AFYA) Using Too Much Debt? Feb 16
A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA) Jan 29
New 90-day low: US$22.80 Jan 28
The Trends At Afya (NASDAQ:AFYA) That You Should Know About Jan 12
What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago? Dec 24
Afya BOD approves share buyback program Dec 23
New 90-day low: US$23.75 Dec 12
Revenue and earnings miss expectations Dec 05
Afya reports Q3 results Dec 03
Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry? Dec 03
Afya Limited to Report Q3, 2020 Results on Dec 03, 2020 Nov 25
Earnings and Revenue Growth Forecasts NasdaqGS:AFYA - Analysts future estimates and past financials data (BRL Millions) Date Revenue Earnings Free Cash Flow Cash from Op Avg. No. Analysts 12/31/2026 3,997 865 1,227 1,376 6 12/31/2025 3,675 762 1,131 1,159 7 12/31/2024 3,289 630 929 950 7 6/30/2024 3,067 553 893 1,173 N/A 3/31/2024 2,970 478 838 1,130 N/A 12/31/2023 2,876 386 798 1,044 N/A 9/30/2023 2,730 355 759 1,024 N/A 6/30/2023 2,587 337 667 953 N/A 3/31/2023 2,473 356 606 897 N/A 12/31/2022 2,329 374 547 844 N/A 9/30/2022 2,243 352 495 818 N/A 6/30/2022 2,117 329 430 738 N/A 3/31/2022 1,891 245 434 730 N/A 12/31/2021 1,719 223 354 631 N/A 9/30/2021 1,566 235 387 591 N/A 6/30/2021 1,421 257 329 503 N/A 3/31/2021 1,323 300 300 449 N/A 12/31/2020 1,201 292 234 372 N/A 9/30/2020 1,077 285 283 377 N/A 6/30/2020 974 257 234 380 N/A 3/31/2020 878 212 210 343 N/A 12/31/2019 751 154 178 299 N/A 9/30/2019 636 128 137 247 N/A 6/30/2019 522 106 119 156 N/A 3/31/2019 417 110 93 120 N/A 12/31/2018 334 86 59 80 N/A 12/31/2017 216 45 N/A 40 N/A
Show more
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AFYA's forecast earnings growth (15.2% per year) is above the savings rate (2.6%).
Earnings vs Market: AFYA's earnings (15.2% per year) are forecast to grow slower than the US market (15.5% per year).
High Growth Earnings: AFYA's earnings are forecast to grow, but not significantly .
Revenue vs Market: AFYA's revenue (10.1% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: AFYA's revenue (10.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AFYA's Return on Equity is forecast to be low in 3 years time (19.6%).
Discover growth companies Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}